|
Volumn 42, Issue 4, 2010, Pages 1336-1340
|
Which Is the Most Suitable and Effective Route of Administration for Mesenchymal Stem Cell-Based Immunomodulation Therapy in Experimental Kidney Transplantation: Endovenous or Arterial?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
ENHANCED GREEN FLUORESCENT PROTEIN;
IMMUNOGLOBULIN;
ALLOTRANSPLANTATION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
EXPERIMENTAL RAT;
EXPERIMENTAL TRANSPLANTATION;
FISCHER 344 RAT;
GLOMERULUS;
HISTOPATHOLOGY;
IMMUNOHISTOCHEMISTRY;
IMMUNOMODULATION;
INFLAMMATORY INFILTRATE;
INTERMETHOD COMPARISON;
KIDNEY FUNCTION TEST;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
KIDNEY TUBULE;
LEWIS RAT;
MALE;
MESENCHYMAL STEM CELL TRANSPLANTATION;
NEPHRECTOMY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RENAL ARTERY;
SPRAGUE DAWLEY RAT;
TAIL;
TRANSGENIC RAT;
|
EID: 77952563752
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.03.081 Document Type: Article |
Times cited : (44)
|
References (11)
|